Current Opinion in Immunology

Current Opinion in Immunology is published by Elsevier Ltd and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Immune Cell Function and Interaction, T-cell and B-cell Immunology and Immunotherapy and Immune Responses, together about 51.3% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)

Current Opinion in Immunology aims to stimulate scientifically grounded, interdisciplinary, multi-scale debate and exchange of ideas. It contains polished, concise and timely reviews and opinions, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, the authors are encouraged to give their subjective opinion of the topics discussed.In Current Opinion in Immunology we help the reader by providing in a systematic manner: 1. The views of experts on current advances in their field in a clear and readable form. 2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.Current Opinion in Immunology will serve as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students.Expertise - Editors and Editorial Board bring depth and breadth of expertise and experience to the journal.Discoverability - Articles get high visibility and maximum exposure on an industry-leading platform that reaches a vast global audience.Division of the subject into sections The subject of Immunology is divided into 8 themed sections and 2 special sections, each of which is reviewed once a year.Innate immunityTumour immunologyLymphocyte development and activationAntigen processingVaccinesAllergy and hypersensitivityHost pathogensAutoimmunitySelection of topics to be reviewed Section Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected. The Editorial Board provides support to the Editors and the Section Editors with their comments and suggestions on names and topics. Review articles in Current Opinion in Immunology are by invitation only.Review Articles Authors write short review articles in which they present recent developments in their subject, emphasizing the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the previous two years.Editorial Overview Section Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments.This successful format has made Current Opinion in Immunology one of the most highly regarded and highly cited review journals in the field.

From the journal's Aims & Scope

Research area (LetPub): Immunology

Editor-in-chief Eric GershwinPublisher website

Editorial board by country: 6 in mainland China (about 18%); most named United States 11, Mainland China 6, Italy 6, United Kingdom 2, France 2 (33 members with a country) Editorial board ↗Publisher website · 2026-10-01

CAS Journal Ranking

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Impact

Impact factor

5.51LetPub · 2026-09-13

Impact factor (publisher)

5.6Publisher website · 2026-10-01

CiteScore 2026-06

10LetPub · 2026-09-13

CiteScore (publisher)

10Publisher website · 2026-10-01

SJR 2026-06

3.01LetPub · 2026-09-13

SNIP 2026-06

1.33LetPub · 2026-09-13

h-index

177LetPub · 2026-09-13

h-index

249OpenAlex · 2026-10-01

i10-index

3,294OpenAlex · 2026-10-01

2-year mean citedness

4.42OpenAlex · 2026-10-01

Self-citation rate

0%LetPub · 2026-09-13

Share of gold OA articles

39.86%LetPub · 2026-09-13

Volume

Articles per year

136LetPub · 2026-09-13

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Other sources

Average review time (community reports)

6–12 weeksLetPub · 2026-09-13

Average acceptance (community reports)

Fairly hardLetPub · 2026-09-13

Submission to first decision

6 daysPublisher website · 2026-10-01

First decision after review

40 daysPublisher website · 2026-10-01

Submission to acceptance

58 daysPublisher website · 2026-10-01

Acceptance to publication

21 daysPublisher website · 2026-10-01

Peer review

Single anonymous peer reviewPublisher website

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Publisher

Elsevier Ltd

Country or region

ENGLAND

Language

English

Frequency

Bimonthly

Founded

1988

ISSN

0952-7915

Electronic ISSN

1879-0372

Official links

• Journal homepage ↗OpenAlex
• Submission system ↗LetPub
• Special issues ↗Publisher website